Fosun Pharma USA Inc. is 10% Owner at NATURES SUNSHINE PRODUCTS INC (NATR). They have made 1 open-market trade across 1 company since 2025, most recently 2025-06-27.
CIK 0002071437
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NATR | SELL | 2025-06-27 | 2025-06-27 | $11.46 | $65.4M | +7.8% | +1.4% | +11.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.